Journal article 626 views 81 downloads
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors
Molecular Therapy - Methods & Clinical Development, Volume: 16, Pages: 21 - 31
Swansea University Author: Luke Davies
-
PDF | Version of Record
Copyright: 2019 The Authors.This is an open access article under the CC BY license
Download (2.15MB)
DOI (Published version): 10.1016/j.omtm.2019.10.004
Abstract
Tissue-resident macrophages exhibit specialized phenotypes dependent on their in vivo physiological niche. Investigation of their function often relies upon complex whole mouse transgenic studies. While some appropriate lineage-associated promoters exist, there are no options for tissue-specific tar...
Published in: | Molecular Therapy - Methods & Clinical Development |
---|---|
ISSN: | 2329-0501 |
Published: |
Elsevier BV
2020
|
Online Access: |
Check full text
|
URI: | https://cronfa.swan.ac.uk/Record/cronfa61697 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
first_indexed |
2022-11-07T14:15:06Z |
---|---|
last_indexed |
2023-01-13T19:22:37Z |
id |
cronfa61697 |
recordtype |
SURis |
fullrecord |
<?xml version="1.0"?><rfc1807><datestamp>2022-11-07T14:17:05.8939355</datestamp><bib-version>v2</bib-version><id>61697</id><entry>2022-10-31</entry><title>Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors</title><swanseaauthors><author><sid>ff080296775381560053d5e3a6e81745</sid><ORCID>0000-0001-7767-4060</ORCID><firstname>Luke</firstname><surname>Davies</surname><name>Luke Davies</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-10-31</date><deptcode>BMS</deptcode><abstract>Tissue-resident macrophages exhibit specialized phenotypes dependent on their in vivo physiological niche. Investigation of their function often relies upon complex whole mouse transgenic studies. While some appropriate lineage-associated promoters exist, there are no options for tissue-specific targeting of macrophages. We have developed full protocols for in vivo productive infection (defined by stable transgene expression) of tissue-resident macrophages with lentiviral vectors, enabling RNA and protein overexpression, including expression of small RNA species such as shRNA, to knock down and modulate gene expression. These approaches allow robust infection of peritoneal tissue-resident macrophages without significant infection of other cell populations. They permit rapid functional study of macrophages in homeostatic and inflammatory settings, such as thioglycolate-induced peritonitis, while maintaining the cells in their physiological context. Here we provide detailed protocols for the whole workflow: viral production, purification, and quality control; safety considerations for administration of the virus to mice; and assessment of in vivo transduction efficiency and the low background levels of inflammation induced by the virus. In summary, we present a quick and accessible protocol for the rapid assessment of gene function in peritoneal tissue-resident macrophages in vivo.</abstract><type>Journal Article</type><journal>Molecular Therapy - Methods &amp; Clinical Development</journal><volume>16</volume><journalNumber/><paginationStart>21</paginationStart><paginationEnd>31</paginationEnd><publisher>Elsevier BV</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>2329-0501</issnPrint><issnElectronic/><keywords/><publishedDay>13</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2020</publishedYear><publishedDate>2020-03-13</publishedDate><doi>10.1016/j.omtm.2019.10.004</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><funders>P.R.T. is funded by a Wellcome Trust Investigator Award (107964/Z/15/Z), and this work was supported in part by the UK Dementia Research Institute. L.C.D. is funded by the Wellcome Trust (103973/Z/14/Z)</funders><projectreference/><lastEdited>2022-11-07T14:17:05.8939355</lastEdited><Created>2022-10-31T12:37:57.0375818</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Natacha</firstname><surname>Ipseiz</surname><order>1</order></author><author><firstname>Magdalena A.</firstname><surname>Czubala</surname><order>2</order></author><author><firstname>Valentina M.T.</firstname><surname>Bart</surname><order>3</order></author><author><firstname>Luke</firstname><surname>Davies</surname><orcid>0000-0001-7767-4060</orcid><order>4</order></author><author><firstname>Robert H.</firstname><surname>Jenkins</surname><order>5</order></author><author><firstname>Paul</firstname><surname>Brennan</surname><order>6</order></author><author><firstname>Philip R.</firstname><surname>Taylor</surname><order>7</order></author></authors><documents><document><filename>61697__25671__38fbd3e6ee0447c289198a0230b85ddb.pdf</filename><originalFilename>61697.pdf</originalFilename><uploaded>2022-11-07T14:15:39.1351658</uploaded><type>Output</type><contentLength>2256227</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>Copyright: 2019 The Authors.This is an open access article under the CC BY license</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>http://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807> |
spelling |
2022-11-07T14:17:05.8939355 v2 61697 2022-10-31 Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors ff080296775381560053d5e3a6e81745 0000-0001-7767-4060 Luke Davies Luke Davies true false 2022-10-31 BMS Tissue-resident macrophages exhibit specialized phenotypes dependent on their in vivo physiological niche. Investigation of their function often relies upon complex whole mouse transgenic studies. While some appropriate lineage-associated promoters exist, there are no options for tissue-specific targeting of macrophages. We have developed full protocols for in vivo productive infection (defined by stable transgene expression) of tissue-resident macrophages with lentiviral vectors, enabling RNA and protein overexpression, including expression of small RNA species such as shRNA, to knock down and modulate gene expression. These approaches allow robust infection of peritoneal tissue-resident macrophages without significant infection of other cell populations. They permit rapid functional study of macrophages in homeostatic and inflammatory settings, such as thioglycolate-induced peritonitis, while maintaining the cells in their physiological context. Here we provide detailed protocols for the whole workflow: viral production, purification, and quality control; safety considerations for administration of the virus to mice; and assessment of in vivo transduction efficiency and the low background levels of inflammation induced by the virus. In summary, we present a quick and accessible protocol for the rapid assessment of gene function in peritoneal tissue-resident macrophages in vivo. Journal Article Molecular Therapy - Methods & Clinical Development 16 21 31 Elsevier BV 2329-0501 13 3 2020 2020-03-13 10.1016/j.omtm.2019.10.004 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University P.R.T. is funded by a Wellcome Trust Investigator Award (107964/Z/15/Z), and this work was supported in part by the UK Dementia Research Institute. L.C.D. is funded by the Wellcome Trust (103973/Z/14/Z) 2022-11-07T14:17:05.8939355 2022-10-31T12:37:57.0375818 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Natacha Ipseiz 1 Magdalena A. Czubala 2 Valentina M.T. Bart 3 Luke Davies 0000-0001-7767-4060 4 Robert H. Jenkins 5 Paul Brennan 6 Philip R. Taylor 7 61697__25671__38fbd3e6ee0447c289198a0230b85ddb.pdf 61697.pdf 2022-11-07T14:15:39.1351658 Output 2256227 application/pdf Version of Record true Copyright: 2019 The Authors.This is an open access article under the CC BY license true eng http://creativecommons.org/licenses/by/4.0/ |
title |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
spellingShingle |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors Luke Davies |
title_short |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
title_full |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
title_fullStr |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
title_full_unstemmed |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
title_sort |
Effective In Vivo Gene Modification in Mouse Tissue-Resident Peritoneal Macrophages by Intraperitoneal Delivery of Lentiviral Vectors |
author_id_str_mv |
ff080296775381560053d5e3a6e81745 |
author_id_fullname_str_mv |
ff080296775381560053d5e3a6e81745_***_Luke Davies |
author |
Luke Davies |
author2 |
Natacha Ipseiz Magdalena A. Czubala Valentina M.T. Bart Luke Davies Robert H. Jenkins Paul Brennan Philip R. Taylor |
format |
Journal article |
container_title |
Molecular Therapy - Methods & Clinical Development |
container_volume |
16 |
container_start_page |
21 |
publishDate |
2020 |
institution |
Swansea University |
issn |
2329-0501 |
doi_str_mv |
10.1016/j.omtm.2019.10.004 |
publisher |
Elsevier BV |
college_str |
Faculty of Medicine, Health and Life Sciences |
hierarchytype |
|
hierarchy_top_id |
facultyofmedicinehealthandlifesciences |
hierarchy_top_title |
Faculty of Medicine, Health and Life Sciences |
hierarchy_parent_id |
facultyofmedicinehealthandlifesciences |
hierarchy_parent_title |
Faculty of Medicine, Health and Life Sciences |
department_str |
Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine |
document_store_str |
1 |
active_str |
0 |
description |
Tissue-resident macrophages exhibit specialized phenotypes dependent on their in vivo physiological niche. Investigation of their function often relies upon complex whole mouse transgenic studies. While some appropriate lineage-associated promoters exist, there are no options for tissue-specific targeting of macrophages. We have developed full protocols for in vivo productive infection (defined by stable transgene expression) of tissue-resident macrophages with lentiviral vectors, enabling RNA and protein overexpression, including expression of small RNA species such as shRNA, to knock down and modulate gene expression. These approaches allow robust infection of peritoneal tissue-resident macrophages without significant infection of other cell populations. They permit rapid functional study of macrophages in homeostatic and inflammatory settings, such as thioglycolate-induced peritonitis, while maintaining the cells in their physiological context. Here we provide detailed protocols for the whole workflow: viral production, purification, and quality control; safety considerations for administration of the virus to mice; and assessment of in vivo transduction efficiency and the low background levels of inflammation induced by the virus. In summary, we present a quick and accessible protocol for the rapid assessment of gene function in peritoneal tissue-resident macrophages in vivo. |
published_date |
2020-03-13T04:20:42Z |
_version_ |
1763754369634795520 |
score |
11.03559 |